Vasoactive substances: nitric oxide and endothelial dysfunction in atherosclerosis.
about
The Renin-Angiotensin-aldosterone system in vascular inflammation and remodelingEndothelial dysfunction in diabetes: pathogenesis, significance, and treatment.Therapeutic approaches to drug targets in atherosclerosis.Granulocyte-CSF induced inflammation-associated cardiac thrombosis in iron loading mouse heart and can be attenuated by statin therapy.Identification of 13-hydroxy-14,15-epoxyeicosatrienoic acid as an acid-stable endothelium-derived hyperpolarizing factor in rabbit arteries.Therapeutic Effects of PPAR α on Neuronal Death and Microvascular Impairment.Emerging role of epoxyeicosatrienoic acids in coronary vascular function.Vascular dysfunction in glycogen storage disease type ITherapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus.Iron stores in regular blood donors in Lagos, NigeriaRole of TNF-alpha in vascular dysfunction.Sphingosine-1-phosphate and modulation of vascular toneThe molecular sources of reactive oxygen species in hypertension.Vascular endothelial growth factor regulation of Weibel-Palade-body exocytosisFeed-forward signaling of TNF-alpha and NF-kappaB via IKK-beta pathway contributes to insulin resistance and coronary arteriolar dysfunction in type 2 diabetic miceDetection of human CYP2C8, CYP2C9, and CYP2J2 in cardiovascular tissues.Sphingosine 1-phosphate activates Weibel-Palade body exocytosis.Role of MCP-1 in tumor necrosis factor-alpha-induced endothelial dysfunction in type 2 diabetic mice.Coenzyme Q(10) , endothelial function, and cardiovascular disease.Novel biomarkers of coronary microvascular disease.Inhibition of platelet aggregation ex vivo is repressed in apolipoprotein E deficient mice.Effect of homocysteine on nitric oxide production in coronary microvascular endothelial cells.Effect of high-dose intravenous eletriptan on coronary artery diameter.Quinone-enhanced ascorbate reduction of nitric oxide: role of quinone redox potential.Helicobacter pylori-induced inhibition of vascular endothelial cell functions: a role for VacA-dependent nitric oxide reduction.Statins exert endothelial atheroprotective effects via the KLF2 transcription factor.Adolescent vulnerability to cardiovascular consequences of chronic social stress: Immediate and long-term effects of social isolation during adolescence.Myricetin derived from Hovenia dulcis Thunb. ameliorates vascular endothelial dysfunction and liver injury in high choline-fed mice.
P2860
Q21284671-48040AC7-13D6-450F-968B-3318369E562CQ33776230-C50DB9A8-9E56-44F9-89DB-F93C1B0EF08AQ33906710-90C00A4B-29E7-453E-AEE8-BE96D0083243Q34984092-9788CDBF-59DA-4418-9D86-E4FC58906E2FQ35001637-F902A10B-62D8-403A-A9C7-195C87E9783CQ35078274-E1B29FF7-8146-47FD-8114-639D6951C376Q36458500-A40EF8DF-D407-4FC6-90FF-8E4F18C4D5B6Q36714119-D18A2BF2-C152-4A1A-93B8-B320C189523AQ36892489-17F3CA03-B079-42D6-A7DB-36FDD0C052E7Q36937071-0CE93E72-57B6-43BF-B8D0-793F52934F36Q37050343-9D8D8D73-1630-4ACA-8532-58C3BFB86E05Q37171310-C3388D4F-6B12-402D-A29D-DCA4FA1E6608Q37196365-15C02A17-ED80-44C0-92F8-80187AEEB8C6Q37250071-3F51187F-C19F-4220-AEEF-F6E8E73CBFD5Q37276227-477A0A09-4FCD-407C-A0CE-08036892F386Q37355303-D23EA3D9-6351-4873-8C07-6129FA07EC55Q37388935-97AB4250-FC67-4718-A6D1-06BEA547BCE1Q37406302-6D9212AC-9A06-44D5-973A-0ABFBA34A98DQ37889812-7B2D3D18-9FCB-4240-AB47-AC6BC3B45BDBQ38854433-5318DA7F-EAB1-462D-BFF9-98C8D3107690Q42512335-7A02B3BE-5A34-41AA-A48F-7A93DC8D7F74Q42514335-6CC85B3F-3573-45EB-A93B-787A7B57E400Q44935647-0FCBAE43-C309-45D8-BFE4-A0E51891D04BQ45129257-E0AA4E97-CB44-46EF-B314-AEE6AB5612DDQ46460211-E6A697E8-6D5E-4738-9CF6-4D3B61C32883Q46477118-900DA62E-4307-4F12-B566-C2EEE14B5198Q47569635-EB427245-9A97-4716-922F-AD5DBB34F829Q50447912-EC59856E-B4EC-4799-8ADF-07439EFD42C9
P2860
Vasoactive substances: nitric oxide and endothelial dysfunction in atherosclerosis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Vasoactive substances: nitric oxide and endothelial dysfunction in atherosclerosis.
@ast
Vasoactive substances: nitric oxide and endothelial dysfunction in atherosclerosis.
@en
type
label
Vasoactive substances: nitric oxide and endothelial dysfunction in atherosclerosis.
@ast
Vasoactive substances: nitric oxide and endothelial dysfunction in atherosclerosis.
@en
prefLabel
Vasoactive substances: nitric oxide and endothelial dysfunction in atherosclerosis.
@ast
Vasoactive substances: nitric oxide and endothelial dysfunction in atherosclerosis.
@en
P1476
Vasoactive substances: nitric oxide and endothelial dysfunction in atherosclerosis.
@en
P2093
Guilia Russo
Jane A Leopold
P304
P356
10.1016/S1537-1891(02)00250-1
P577
2002-05-01T00:00:00Z